Evenity®
Evenity® (Romosozumab-aqqg) is an injectable medication indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Please refer to the full prescribing information.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Amgen |
CLASS: Biologic Subcu Injection |
PRESCRIBED BY: Various |
HOW ADMINISTERED: Injection |
FREQUENCY: 1 Monthly for 12 months |
Length of infusion: N/A |
FOR MORE INFORMATION: |